Anna Jewell
Anna Jewell is the director of services, research and innovation at Pancreatic Cancer UK, who remarked on the excitement surrounding the trial results of daraxonrasib, highlighting its potential to extend survival for advanced pancreatic cancer patients and the importance of making such treatments available.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
Anna Jewell, the director of services, research and innovation at Pancreatic Cancer UK, said the results were 'exciting'.
8